Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.28
-0.07-5.19%
At close: -
$1.32
0.043.13%
After Hours: 6:40 PM EDT
Comments
Loading...
RenovoRx Analyst Ratings and Price Targets | NASDAQ:RNXT | Benzinga
RenovoRx Inc has a consensus price target of $7.88 based on the ratings of 5 analysts. The high is $13 issued by Roth MKM on August 18, 2023. The low is $3 issued by HC Wainwright & Co. on May 19, 2025. The 3 most-recent analyst ratings were released by Ascendiant Capital, HC Wainwright & Co., and Ascendiant Capital on June 5, 2025, May 19, 2025, and April 28, 2025, respectively. With an average price target of $8.5 between Ascendiant Capital, HC Wainwright & Co., and Ascendiant Capital, there's an implied 543.94% upside for RenovoRx Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
HC Wainwright & Co.
Alliance Global Partners
Roth MKM
1calculated from analyst ratings
Analyst Ratings for RenovoRx
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/05/2025 | Buy Now | 771.21% | Ascendiant Capital | Edward Woo76% | $11 → $11.5 | Maintains | Buy | Get Alert |
| 05/19/2025 | Buy Now | 127.27% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 04/28/2025 | Buy Now | 733.33% | Ascendiant Capital | Edward Woo76% | $9 → $11 | Maintains | Buy | Get Alert |
| 04/04/2025 | Buy Now | 127.27% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2025 | Buy Now | 127.27% | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $3 | Initiates | → Buy | Get Alert |
| 12/10/2024 | Buy Now | 581.82% | Ascendiant Capital | Edward Woo76% | $8.25 → $9 | Maintains | Buy | Get Alert |
| 09/12/2024 | Buy Now | 525% | Ascendiant Capital | Edward Woo76% | $8 → $8.25 | Maintains | Buy | Get Alert |
| 06/17/2024 | Buy Now | 506.06% | Ascendiant Capital | Edward Woo76% | → $8 | Initiates | → Buy | Get Alert |
| 02/02/2024 | Buy Now | 203.03% | Alliance Global Partners | Scott Henry46% | → $4 | Initiates | → Buy | Get Alert |
| 11/15/2023 | Buy Now | — | Maxim Group | Jason McCarthy40% | — | Downgrade | Buy → Hold | Get Alert |
| 08/18/2023 | Buy Now | 884.85% | Roth MKM | Scott Henry46% | $14 → $13 | Maintains | Buy | Get Alert |
FAQ
What is the target price for RenovoRx (RNXT) stock?
The latest price target for RenovoRx (NASDAQ:RNXT) was reported by Ascendiant Capital on June 5, 2025. The analyst firm set a price target for $11.50 expecting RNXT to rise to within 12 months (a possible 771.21% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for RenovoRx (RNXT)?
The latest analyst rating for RenovoRx (NASDAQ:RNXT) was provided by Ascendiant Capital, and RenovoRx maintained their buy rating.
When was the last upgrade for RenovoRx (RNXT)?
There is no last upgrade for RenovoRx
When was the last downgrade for RenovoRx (RNXT)?
The last downgrade for RenovoRx Inc happened on November 15, 2023 when Maxim Group changed their price target from N/A to N/A for RenovoRx Inc.
When is the next analyst rating going to be posted or updated for RenovoRx (RNXT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RenovoRx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RenovoRx was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.
Is the Analyst Rating RenovoRx (RNXT) correct?
While ratings are subjective and will change, the latest RenovoRx (RNXT) rating was a maintained with a price target of $11.00 to $11.50. The current price RenovoRx (RNXT) is trading at is $1.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
